Safety and immunogenicity of influenza A(H3N2) component vaccine in juvenile systemic lupus erythematosus.
Aikawa NE, Borba EF, Balbi VA, Sallum AME, Buscatti IM, Campos LMA, Kozu KT, Garcia CC, Capão ASV, de Proença ACT, Leon EP, da Silva Duarte AJ, Lopes MH, Silva CA, Bonfá E.
Aikawa NE, et al. Among authors: balbi va.
Adv Rheumatol. 2023 Nov 28;63(1):55. doi: 10.1186/s42358-023-00339-7.
Adv Rheumatol. 2023.
PMID: 38017564
Clinical Trial.